2 new tests are available in the EMC:
- Determination of the exact amount of antibodies to immunoglobulin G (IgG)SARS-CoV-2 S-protein
- Qualitative determination of the level of antibodies to immunoglobulin M (IgM) S-protein SARS-CoV-2
Efficiency – 100%
Availability of results – 12 hours, emergency - 2 hours
The method is chemiluminescent immunoassay (IHLA)
Quantitative determination of antibodies to SARS-CoV-2 immunoglobulin G S protein makes it possible to assess the dynamics of antibody build-up and the strength of the immune response. It is also being conducted to evaluate the effectiveness of vaccination against COVID-19.
Qualitative detection of the level of antibodies to immunoglobulin M (IgM)The S-protein is used as an auxiliary diagnostic method for COVID-19.
Using the test, it can be determined that:
- the virus has recently entered the body
- the acute period of the disease has passed, but the person is still ill
- the person has recovered/COVID-19 is missing